NEJM Evidence

aka NEJM Evid

NEJM Group's newer journal for clinical trials and trial methodology, publishing rigorous randomised studies that fall just outside the parent journal's remit.

NEJM Evidence has appeared monthly since 2022 and publishes randomised trials, pragmatic and adaptive designs, and methods pieces (Stats, STAT! and trial-design tutorials), including oncology studies on dosing, de-escalation and screening. Subscription-based with the NEJM Group editorial standards.